Advanced Therapies Week 2022 | Strategies to increase cell therapy manufacturing capabilities

Shannon Eaker, PhD, Cytiva, Marlborough, MA, describes important considerations when aiming to expand the capabilities of cell therapy manufacturers, including the need to increase recruitment and training of highly skilled workers as well as retaining existing workers. Dr Eaker additionally highlights constraints in the supply chain, and factoring in the scalability of a product in its design. The advent of automation and digitization in the form of electronic batch records will also aim to address the aforementioned issues by streamlining the manufacturing process. This interview took place at Advanced Therapies Week 2022.